stockrow
Friday 6 November 2026
Export MED’s income statement to Excel — free account
MEDIFAST INC
MED Consumer Cyclical Personal Services
MEDIFAST INC’s revenue for fiscal 2025 (year ended December 2025) was $385.8 million, down 36.0% from fiscal 2024.
- Revenue
- −19.4%
- EPS
- −645.8%
- Free cash flow
- −73.3%
Quarter to September 2026, against a year earlier
12.81
0.34
−2.59%
Follow MED
Alert me
| Sep '26 | Jun '26 | Mar '26 | Dec '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 |
+8 more quarters Free account |
P/S ratio |
0.43 | 0.37 | 0.32 | 0.30 | |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
P/Operating CF |
39.09 | 69.62 | 431.35 | (22.22) | |
P/B ratio |
0.71 | 0.60 | 0.57 | 0.59 | |
Price to Tangible BV |
0.71 | 0.60 | 0.57 | 0.59 | |
EV/Sales |
(0.02) | (0.04) | (0.05) | (0.03) | |
EV/EBITDA |
0.23 | 2.09 | 7.47 | 17.88 | |
EV/Operating CF |
200.38 | (1.50) | (4.92) | (1.67) | |
EV/FCF |
0.19 | 0.68 | 0.74 | 0.45 | |
Quick Ratio |
4.22 | 4.21 | 4.13 | 4.01 | |
Current Ratio |
4.82 | 4.86 | 4.80 | 4.69 | |
Net Debt/EBITDA |
10.06 | 164.71 | (7,039.42) | 37.21 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
1.18 | 1.20 | 1.30 | 1.45 | |
Operating CF/Net income |
(0.19) | (0.55) | (0.12) | 0.29 | |
Capex/Depreciation |
(0.19) | (0.29) | 0.77 | (0.41) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
96.32% | 75.57% | 72.39% | 79.82% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
2.57% | 2.38% | 2.49% | 2.89% | |
Graham Net Nets |
1.11 | 1.17 | 1.32 | 1.30 | |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
(32.00%) | (21.96%) | (17.86%) | (15.92%) | |
Free Cash Flow Yield |
(21.11%) | (16.35%) | (22.11%) | (21.93%) | |
Revenue per Share |
6.44 | 6.86 | 6.91 | 6.84 | |
Operating CF per Share |
0.29 | 0.15 | 0.02 | (0.48) | |
Capex per Share |
(0.04) | (0.09) | 0.23 | (0.12) | |
Free Cash Flow per Share |
0.26 | 0.07 | 0.25 | (0.60) | |
Cash per Share |
15.43 | 15.25 | 15.35 | 15.23 | |
Shareholders Equity per Share |
16.12 | 17.64 | 17.96 | 18.11 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
16.12 | 17.64 | 17.96 | 18.11 | |
Free Cash Flow |
2.87 | 0.73 | 2.80 | (6.63) | |
Working Capital |
160.06 | 160.47 | 160.45 | 158.72 | |
Capital Expenditures |
(0.43) | (0.97) | 2.54 | (1.35) | |
Net Current Asset Value |
142.45 | 138.01 | 148.27 | 152.63 | |
EV/EBIT |
0.15 | 0.67 | 1.12 | 0.81 | |
Capex to Sales |
0.01 | 0.01 | (0.03) | 0.02 | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
2.56 | 2.67 | 2.95 | 2.88 | |
Average Payables |
40.02 | 38.33 | 45.04 | 47.43 | |
Average Inventory |
22.20 | 25.69 | 30.38 | 31.32 | |
Average Assets |
253.99 | 264.87 | 266.03 | 266.09 | |
Average Common Equity |
197.49 | 206.19 | 204.32 | 204.51 |
Columns are period end dates · fundamentals updated 2 Nov 2026